Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > StageZero Twitter - FAQ on the Acquisition
View:
Post by Deadornot on Apr 07, 2021 4:58pm

StageZero Twitter - FAQ on the Acquisition

https://twitter.com/StageZeroLS/status/1379899290613645312?s=20
Comment by Deadornot on Apr 07, 2021 4:59pm
This is... this is GOOD
Comment by davewho on Apr 07, 2021 5:10pm
. How is this acquisition beneficial to StageZero Life Sciences? A. Cancer tests have to be administered by a healthcare provider, preferably a physician experienced in cancer care. StageZero has now partnered with an innovative, telehealth-based Oncology/early disease group with an established presence in all 50 US states. Patients and employers/organizations will now have access to leading ...more  
Comment by Nailbiter1 on Apr 07, 2021 5:16pm
This post has been removed in accordance with Community Policy
Comment by ItsDolph on Apr 07, 2021 5:16pm
Wow that's some great info, thanks so much for posting, really clears a lot of things up. Good to hear they will have a presence in all 50 states. This is really just the beginning of their rollout of Aristotle with these clinics... feeling a lot better about my investment decision today, I plan to hold long term :)
Comment by LeoSeducer67 on Apr 07, 2021 5:19pm
Should have put this out before now
Comment by Deadornot on Apr 07, 2021 5:21pm
They should have. But this is obviously in response to the doubt and bloodbath. 
Comment by Liked2Think on Apr 07, 2021 5:24pm
Imagine if it had been part of the NR. Should had been a no brainer on the part of management. Its nice to see but if they stop it here I dont see much to help us right now. Why can there not be another CC when Tripp just takes questions.  Every single time the question portion is rushed. Imagine another CC is put out there to happen and at the start of it Tripp introduces us to Stages ...more  
Comment by LithLover on Apr 07, 2021 6:14pm
Agreed it could have been handled better and he didnt answer the question as I think he was expecting us to all understand the connection.  Good for them to come out with the Q&A, bad for those that were so paper handed to bail without seeing the pieces of the puzzle. Again, the executives at Care Oncology have dozens of patents to treat cancer and inflammations.  We detect and they ...more  
Comment by davewho on Apr 07, 2021 8:15pm
I'm beginning to understand the strategy. James could not care less about the SP they are cashed upped, have steady Covid19 money coming in and have a long term plan to save millions of lives. The deal is not SP connected. The more Aristotle tests Care Oncology sells the more rev szls makes, the more the sp rises and the more the shares held by Care Oncology are worth. Its a growth driven plan ...more  
Comment by Liked2Think on Apr 07, 2021 8:18pm
He should care about not surprising the heck out of our only analyst though. Maybe if things had gone better he wouldnt had taken 60% of his valuation off the table. I agree the SP is not the only concern of a ceo but that was ridiculous.
Comment by Nailbiter1 on Apr 07, 2021 8:29pm
This post has been removed in accordance with Community Policy
Comment by RelevantStock on Apr 07, 2021 10:16pm
You should be more respectful, Clarus is the main architect of the stock price rise before that confusing launch.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities